Healthcare Industry News: Olympus
News Release - May 3, 2016
NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of SalesBEDFORD, Mass.--(Healthcare Sales & Marketing Network)--NinePoint Medical, Inc., a transformative medical device company that is pioneering the clinical use of a real-time imaging platform based upon a proprietary optical coherence tomography (OCT) technology, announced today the appointment of John Temple as Vice President of Sales. Mr. Temple reports directly to NinePoint Medical’s President and CEO, Christopher R. von Jako, Ph.D.
“We are delighted to welcome such an accomplished sales executive to the NinePoint Medical team. Not only does John bring tremendous commercial leadership experience, but also in-depth gastroenterology industry knowledge and relationships,” said Dr. von Jako. “John’s exceptional track record will be invaluable as we continue to deliver on our growth plans with the NvisionVLE® Imaging System.”
Mr. Temple joins NinePoint Medical with over 25 years of sales, management, and leadership experience in the medical device business with both capital and single-use devices. His experiences span the continuum of medical device product development, from ideation to successful launches and sales execution. Prior to joining NinePoint Medical, Mr. Temple served as a key leader on the executive management team at Olympus America Inc. as Vice President of Sales for eight years. Over his 24-year career with Olympus, he held leadership roles of increasing responsibility within sales where he was responsible for the gastroenterology, pulmonary, surgical, digital integration, management information systems, and capsule endoscopy products. Earlier in his career, Mr. Temple worked at KARL STORZ Endoscopy-America, Inc. and Merrell Dow Pharmaceuticals, Inc.
"I have watched NinePoint Medical and its innovative NvisionVLE Imaging System progress over the last several years, and I am impressed by their tremendous accomplishments to date,” commented Mr. Temple. “I am excited to assist the NinePoint Medical team in achieving their vision of improving patient outcomes through advanced imaging."
About the NvisionVLE® Imaging System
The NvisionVLE Imaging System provides a unique and clinically valuable new perspective of esophageal disease: The ability to image within the wall of the esophagus. By providing a high-resolution, real-time scan of the esophagus using Optical Coherence Tomography (OCT) – a technology similar to ultrasound but using infrared light rather than sound waves - the system enables physicians to view structures not evident with conventional imaging, and potentially identify disease that would have otherwise been missed. This groundbreaking technology can provide for improved physician diagnosis and more effective treatment. The NvisionVLE® Imaging System has been cleared by the FDA and is commercially available in the U.S. For more information, please go to www.ninepointmedical.com.
About NinePoint Medical, Inc.
NinePoint Medical is a privately-held medical device company that designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, and ENT, for the evaluation of human tissue microstructure. Using proprietary imaging and software technology, the Company is committed to enabling quicker diagnosis of disease and more effective treatments, while reducing the overall cost of healthcare.
NinePoint Medical is located in suburban Boston, Massachusetts. For more information, please visit www.ninepointmedical.com.
Source: NinePoint Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.